Immunotherapy Doctors Abroad — Page 3

Associate Professor Tahsin Ozatli specializes in breast, lung, and gastrointestinal cancers at Istinye Liv University Hospital.

• Over a decade of experience in oncology
• Worked at Ankara Oncology Clinic and Erzurum Regional Training and Research Hospital
• Promoted to Associate Professor in 2016
• Studied medicine at Selcuk University

Dr. Ozden specializes in medical oncology with over 27 years of experience of experience in internal medicine and oncology.

• Completed medical oncology subspecialty at Kocaeli University Faculty of Medicine
• Practiced internal medicine at multiple hospitals in Turkey
• Graduated from Istanbul University's Cerrahpaşa Faculty of Medicine

Dr. Salman specializes in immunotherapy for various cancers, integrating targeted therapies and cancer vaccines. He trained at prestigious institutions like Memorial Sloan Kettering Cancer Center.

• Associate Professor at Katip Çelebi University with 32 years of experience in medical oncology
• Academic visitor at Moffitt Cancer Center in Florida, USA
• Board member of Turkish Society of Medical Oncology and European Society of Medical Oncology
• Uses comprehensive genomic profiling for personalized treatment plans
• Active in clinical research and experimental medical therapies

Associate Professor of Medical Oncology at İstinye University Liv Hospital Topkapı – specializes in immunotherapy for cancer treatment.

• 15 years of experience of experience in medical oncology
• Member of the American Society of Clinical Oncology (ASCO)
• Published multiple peer-reviewed articles on cancer treatment outcomes
• Focuses on immunotherapy for various cancer types

Professor of Medical Oncology with over 29 years of experience of experience, specializing in advanced cancer treatments at İstinye University Liv Hospital Topkapı.

• Fellowship-trained in Medical Oncology at Trakya University
• Associate Professor and later Professor at Trakya University Faculty of Medicine
• Member of the Turkish Medical Oncology Association

Dr. Liu Shi Xin is the Vice Chairman of the Radiation Oncology Branch of the Chinese Medical Association. He serves as the Discipline Leader of the Oncology Center at Xiamen Humanity Hospital. Dr. Liu specializes in precision radiotherapy for thoracic and abdominal cancers. He is a recipient of the State Council Special Government Allowance for his medical contributions.

• Highly proficient in IMRT, VMAT, and SBRT for lung and esophageal cancers.
• Former President of Jilin Provincial Cancer Hospital.
• Awarded the National Famous Doctor honor for outstanding contributions to oncology.
• Holds leadership roles in the Chinese Anti-Cancer Association particle therapy committee.

Dr. Lucía González Cortijo leads one of Spain's top oncology departments, specializing in immunotherapy for breast and gynecologic cancers.

• 20+ years focused exclusively on oncology
• Principal investigator in 20+ immunotherapy clinical trials
• Trained at MD Anderson Cancer Center Madrid
• Active member of ESMO and ASCO
• Leads La Vida en Rosa Foundation for women's cancer support

Specializing in radiotherapy and oncology, Dr. Karen Drumea brings focused expertise to immunotherapy at Rambam Medical Center.

• Radiotherapy specialist with oncology training
• Works at Rambam Medical Center
• Focuses on integrating radiotherapy with immunotherapy

Uzm. Dr. Erkan Göcen is a Radiation Oncology Specialist at Çerkezköy Private Optimed Hospital (Optimed Health Group). He graduated from İstanbul University, İstanbul Faculty of Medicine (Çapa) in 2003.

Career: He trained and practiced in Radiation Oncology from 2010 to 2012. He worked in public and private health institutions from 2012 to 2016. He served in the private medical sector as a Radiation Oncology Specialist from 2016 to 2023. He has been at Optimed Hospital since 2024.

Clinical interests: cancers of the brain, head and neck, esophagus, stomach, colorectal, pancreas, prostate, bladder, lung, soft tissues (sarcomas), skin, uterus and cervix, and breast. Affiliations: Turkish Society for Radiation Oncology (TROD) and Tekirdağ Medical Chamber. Languages: English and Turkish.

Prof. Myriam Ben Arush is an internationally recognized specialist in pediatric oncology and bone marrow transplantation at Rambam Medical Center.

• Director of Pediatric Division at Ruth Rappaport Children's Hospital
• Recipient of the Chevalier de la Legion d'Honneur in France
• Named one of the world's most caring doctors by the World Medical Association
• Member of the Children's Oncology Group in the USA

Dr. Eytan Aharon Ben-Ami leads the Oncology Division at Sheba Medical Center in Israel. He specialized in sarcoma and bone oncology at the Dana-Farber Cancer Institute. Dr. Ben-Ami founded the Sheba Clinical Research Organization to advance cancer studies. He treats rare bone tumors and soft tissue sarcomas with personalized protocols.

• Heads the Early-Phase Clinical Trials Unit for innovative cancer therapies.
• Authored over 40 scientific publications on molecular mechanisms and early detection.
• Leads Phase I trials in targeted therapy and immunotherapy for rare cancers.
• Works at Sheba Medical Center, a top-10 hospital globally per Newsweek.

Chief Physician of the Oncology Center at Assuta Medical Center, Dr. Tepper specializes in immunotherapy treatments.

• Years of experience in oncology with a focus on innovative therapies
• Leads dedicated teams for personalized treatment plans
• Actively involved in advancing immunotherapy protocols

Dr. Emad Shash is a medical oncologist who has participated in over 70 oncology clinical trials. He serves as the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. Dr. Shash specializes in systemic therapies, including chemotherapy, targeted therapy, and immunotherapy. He holds a Diploma in Hospital Quality Management and Patient Safety from JCI.

• Serves as an ESMO panel voting member and an ASCO committee member.
• Treats breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers.
• Former research physician and medical lead at the EORTC in Brussels.
• Works at Shefaa Al Orman, an ESMO-accredited oncology center treating 6,000 patients annually.

Dr. Jair Bar is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He specializes in treating advanced non-small cell lung cancer using personalized immunotherapy and targeted treatments. Dr. Bar holds a PhD in Molecular Biology and leads a research lab focused on immunotherapy resistance.

• Chair of the Israel Lung Cancer Group.
• Board-certified in both Medical Oncology and Radiotherapy Oncology.
• Treats patients at Sheba Medical Center, a top-10 globally ranked hospital.
• Uses molecular and genetic profiling to create precise cancer treatment plans.

Dr. Nir Kleinmann directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is a pioneer in kidney-sparing laser surgery for complex tumors. Forbes and ResultMed named him among Israel’s Best Doctors for 2025 and 2026. Dr. Kleinmann uses a unique dual-laser system to preserve organ function during cancer treatment.

• Completed urological fellowships at Thomas Jefferson University and McMaster University.
• Expert in minimally invasive treatments for UTUC, kidney stones, and prostate cancer.
• Served as a researcher in the OLYMPUS trial for non-surgical chemoablation.
• Fellow of the American Endourology Society with over 60 scientific publications.

Dr. Raanan Berger is the Director of the Cancer Center at Sheba Medical Center. He was listed in Forbes Israel’s “Best Doctors” in 2025. Dr. Berger specializes in genitourinary oncology and radiates complex prostate tumors. He completed a postdoctoral fellowship at the Dana-Farber/Harvard Cancer Institute.

• Heads the clinical research unit focusing on molecular oncology.
• Co-authored over 20 peer-reviewed papers on prostate cancer and BRCA mutations.
• Member of the American Society of Clinical Oncology (ASCO).
• Performs systemic therapy and radiotherapy at a Top-10 globally ranked hospital.

Prof. Ben Boursi leads groundbreaking research on microbiome's role in cancer therapy – his work is published in Science and featured at ASCO.

• Specializes in gastrointestinal oncology at Sheba Medical Center
• Trained at University of Pennsylvania and top US cancer centers
• Founder of ECOG-ACRIN Microbiome Working Group
• Develops predictive models for early cancer detection
• Board-certified in both Internal Medicine and Medical Oncology

Dr. Maha Yahia is a medical and hemato-oncologist at Shefaa Al Orman International Oncology Hospitals. She served as a Lieutenant Colonel physician in the Egyptian Armed Forces Medical Corps. Dr. Yahia specializes in treatment planning for breast, thoracic, and gastrointestinal cancers. She focuses on immunotherapy, targeted therapy, and complex chemotherapy protocols.

• Former Head of the Clinical Research Support Team at Maadi AFMC.
• Trained at the National Cancer Institute, Cairo University, in hemato-oncology.
• Treats genitourinary, gynecologic, and rare cancers alongside hematologic conditions.
• Works at an ESMO-accredited center that treats 6,000 patients annually.

Principal Investigator in clinical trials focusing on immunotherapy for gynecological cancers – Dr. Oaknin leads cutting-edge research at Hospital Quiron Barcelona.

• Specializes in ovarian, cervical, and endometrial cancer treatments
• Author of over 100 publications and presentations
• Executive board member of GEICO Group
• Faculty member for Gyn-Track in ESMO